Neurons are particularly vulnerable to perturbations in endo-lysosomal transport, as several neurological disorders are caused by a primary deficit in this pathway. In this report, we used positional cloning to show that the spontaneously occurring neurological mutation teetering (tn) is a single nucleotide substitution in hepatocyte growth factor-regulated tyrosine kinase substrate (Hgs/Hrs), a component of the endosomal sorting complex required for transport (ESCRT). The tn mice exhibit hypokenesis, muscle weakness, reduced muscle size and early perinatal lethality by 5-weeks of age. Although HGS has been suggested to be essential for the sorting of ubiquitinated membrane proteins to the lysosome, there were no alterations in receptor tyrosine kinase levels in the central nervous system, and only a modest decrease in tropomyosin receptor kinase B (TrkB) in the sciatic nerves of the tn mice. Instead, loss of HGS resulted in structural alterations at the neuromuscular junction (NMJ), including swellings and ultra-terminal sprouting at motor axon terminals and an increase in the number of endosomes and multivesicular bodies. These structural changes were accompanied by a reduction in spontaneous and evoked release of acetylcholine, indicating a deficit in neurotransmitter release at the NMJ. These deficits in synaptic transmission were associated with elevated levels of ubiquitinated proteins in the synaptosome fraction. In addition to the deficits in neuronal function, mutation of Hgs resulted in both hypermyelinated and dysmyelinated axons in the tn mice, which supports a growing body of evidence that ESCRTs are required for proper myelination of peripheral nerves. Our results indicate that HGS has multiple roles in the nervous system and demonstrate a previously unanticipated requirement for ESCRTs in the maintenance of synaptic transmission.
Endocytic trafficking involves the internalization, endosomal sorting and lysosomal degradation of cell surface cargo. Many factors involved in endosomal sorting in mammalian cells have been identified, and mutations in these components are associated with a variety of neurological disorders. While the function of endosomal sorting components has been intensely studied in immortalized cell lines, it is not known what role these factors play in endosomal sorting in the nervous system. In this study, we show that the teetering (tn) gene encodes the hepatocyte growth factor regulated tyrosine kinase substrate (Hgs), a core component of the endosomal sorting pathway. The tn mice exhibit several signs of motor neuron disease, including reduced muscle mass, muscle weakness and motor abnormalities. Although HGS is predicted to be required for the lysosomal degradation of receptor tyrosine kinases, there was no change in the levels of receptor tyrosine kinases in the spinal cords of the tn mice. Instead, we found that HGS is required for synaptic transmission at the neuromuscular junction and for the proper myelination of the peripheral nervous system.
Citation: Watson JA, Bhattacharyya BJ, Vaden JH, Wilson JA, Icyuz M, Howard AD, et al. (2015) Motor and Sensory Deficits in the teetering Mice Result from Mutation of the ESCRT Component HGS. PLoS Genet 11(6): e1005290. https://doi.org/10.1371/journal.pgen.1005290
Editor: Bruce A. Hamilton, University of California San Diego, UNITED STATES
Received: October 27, 2014; Accepted: May 18, 2015; Published: June 26, 2015
Copyright: © 2015 Watson et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited
Data Availability: All relevant data are within the paper and its Supporting Information files.
Funding: This work was supported by the National Institutes of Health (NS047533 to SMW) and by a Civitan Research Center grant (SMW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing interests: SMW is a paid consultant for Progenra Incorporated. This does not alter the authors’ adherence to any of the PLOS Genetics policies on sharing data and materials, and it does not influence the generation or presentation of the data.
In neurons, endosomal transport and sorting of internalized cargo affects the abundance of plasma membrane proteins and regulates a diverse group of cellular processes such as signal transduction and synaptic vesicle recycling [1–3]. A group of evolutionarily conserved cytosolic proteins referred to as the endosomal sorting complexes required for transport (ESCRT) associate with the endosomal membrane and direct the sorting of internalized cargo [4,5]. Four distinct ESCRT complexes, ESCRT-0, -I, -II and—III, act sequentially to contribute to the sorting of membrane proteins, thus determining if endocytosed receptors are recycled back to the cell surface or are further sorted into intraluminal vesicles (ILVs) within specialized endosomes called multivesicular bodies (MVBs) for their eventual degradation by lysosomes . Receptor degradation rates affect the duration of receptor signaling, and alterations in the turnover of activated receptors have been implicated in a variety of disease processes [7–10].
The ESCRT-0 complex, composed of HGS and signal transducing adaptor molecule 1 (STAM1) [11–13], is essential for the initial recognition of ubiquitinated cargo that will be sorted at the endosomal membrane and degraded upon endo-lysosomal fusion [14,15]. HGS is believed to serve as a master regulator of endo-lysosomal trafficking by binding ubiquitinated cargo and initiating the recruitment of the ESCRT-I, -II, and—III components [16–19]. Given its role in the early stages of endosomal sorting of internalized cell surface receptors, it has been suggested that HGS also plays an important role in the recycling of cargo to the plasma membrane [20–22]. In addition, HGS can bind synaptosomal associated protein 25 (SNAP-25) and prevent SNARE complex formation, thereby inhibiting neurotransmitter secretion  and endosomal fusion . Studies in Drosophila have also implicated HGS in synaptic protein homeostasis and synaptic vesicle rejuvenation . However, despite the insights into HGS function gained from the studies described above, the precise role of HGS in endosomal trafficking has not been determined in the mammalian nervous system.
Disruption of endosomal transport is associated with many neurological disorders . In some instances, a direct link has been demonstrated between the genetic defect and endosomal dysfunction. For example, mutations in both ESCRT components and endosomal-associated factors have been attributed to neurodegeneration . Mutations in multivesicular body protein 2B (CHMP2B), a component of the ESCRT-III complex, are linked to both frontotemporal dementia and amyotrophic lateral sclerosis [7,27,28]. In addition, mutations in kinesin family member 5A (KIF5A) and SPARTIN, which facilitate endosomal trafficking, are associated with motor neuron dysfunction in hereditary spastic paraplegia [29–31]. Together, these findings suggest that motor neurons are particularly vulnerable to deficits in endosomal trafficking and that genes in this pathway may be excellent candidate genes for inherited motor neuron diseases.
In addition to its association with neurodegeneration in the central nervous system, ESCRT dysfunction is also associated with peripheral demyelinating diseases. Mutations in lipopolysaccharide-induced tumor necrosis factor-alpha factor (LITAF)/SIMPLE, that interacts with HGS and STAM1 in the ESCRT-0 complex [32,33], cause a demyelinating form of Charcot Marie Tooth disease [34,35], suggesting that ESCRT-0 is required for myelin formation or stability. By directing activated receptor tyrosine kinases to the lysosome, ESCRT-mediated endosomal sorting provides a mechanism to prevent aberrant signaling that is believed to result in demyelination and degeneration of peripheral axons.
In this study, we used a positional cloning approach to demonstrate that the neurological phenotypes observed in the tn mice are due to a point mutation in Hgs that leads to hypomorphic expression of HGS. The subsequent reduction of HGS caused motor and sensory deficits that were accompanied by peripheral nerve hypermyelination and dysmyelination. Further analysis of motor function demonstrated that the tn mice had reduced muscle development and both structural and functional alterations at the NMJ. These deficits in neuromuscular function were associated with the accumulation of ubiquitinated proteins at the synapse. This report represents the first demonstration that a mutation in an ESCRT-0 component causes a motor and sensory neuropathy and suggests that HGS is required for the sorting of ubiquitinated proteins at the synapse to maintain synaptic transmission at the NMJ.
Cloning of the tn mutation
The tn mutation arose spontaneously in a C3H/HeJ inbred mouse line, resulting in a progressive neurodevelopmental disorder that first presents at 3 weeks of age . Homozygous tn mice exhibit reduced growth, ataxia, hypokinesis and premature death at 4 to 5 weeks of age (Fig 1A–1C) . These deficits are thought to be due to dysgenesis of the brainstem and spinal cord . To identify the minimal chromosomal region harboring the tn mutation, a congenic mouse line was generated by backcrossing the tn mutation onto the C57BL/6J genetic background. Analysis of single nucleotide polymorphisms localized the tn mutation to a 2.8 Mb region on distal chromosome 11 (Fig 1D). We then performed transcriptome analysis of brain RNA to identify nucleotide changes in the coding sequences of the genes located within the tn critical region. Sequence analysis of the 87 genes within the tn critical region only revealed a single nucleotide substitution in the Hgs gene. Genomic sequencing of the Hgs gene from the tn mice confirmed an adenine to guanine transition at position 265, which resulted in a methionine to valine substitution at amino acid 89 (M89V) (Fig 1E). The methionine residue at position 89 of HGS is highly conserved throughout eukaryotic phylogeny (Fig 1F).
(A) Image showing reduced size of 4-week-old Hgstn/tn mice relative to wild type HGS+/+ mice. (B) Body mass of 3- to 5-week-old HGS+/+, heterozygous Hgstn/+ and Hgstn/tn mice. n > 6 mice per genotype. A two-way anova was used to find a significant effect of genotype on body mass. Symbols represent unpaired t-tests corrected for multiple comparisons using the Holm-Sidak method (C) Kaplan-Meier survival curve of wild type (Hgs+/+) and Hgs-mutant mice. The HgsKO allele does not complement the Hgstn allele. A Mantel-Cox test with p<0.001 demonstrated a significant difference between the survival curves of the Hgstn/tn and HrsKO/tn mice as compared to the HgKO/+ Hgstn/+, and Hgs+/+ mice. (D) Meiotic linkage map depicting SNP markers that define the tn critical region. (E) Genomic sequencing of HGS revealed an adenine to guanine change in the Hgstn/tn mice, resulting in a methionine to valine substitution at amino acid 89 of HGS. (F) Schematic of HGS protein structure in eukaryotes, demonstrating the conservation of the methionine residue at position 89 in the VHS domain (orange box). Data are shown as mean ± SE. *p < 0.05 and ***p < 0.001.
The M89V substitution is located in the N-terminal Vps27-HGS-STAM (VHS) domain of HGS that is involved in substrate binding [37,38]. To confirm that this mutation in HGS is responsible for the tn phenotype, a genetic complementation assay was performed by breeding mice that were heterozygous for the tn allele (Hgstn/+) to mice that were heterozygous for a knockout allele of Hgs (Hgstm1S/+, henceforth referred to as HgsKO/+) . The resulting HgsKO/tn offspring exhibited perinatal lethality by postnatal day 40 (Fig 1C) and a neurological phenotype similar to the tn mice, confirming that the tn gene was allelic to Hgs. Since the HgsKO/KO mice die by embryonic day 11 , the enhanced survival of the HgsKO/tn mice indicated that the tn allele was not a null allele of Hgs.
HGS expression in the nervous system is developmentally regulated
To investigate the distribution of Hgs expression in vivo, we performed quantitative polymerase chain reaction (qPCR)on reverse-transcribed RNA isolated from 4-week-old Hgs+/+ wild type mice. Hgs was expressed in all tissues examined, with the highest levels of Hgs detected in the brain and spinal cord (Fig 2A). Consistent with the qPCR data, immunoblot analysis also revealed high levels of HGS in the nervous system of wild type mice (Fig 2B). While the tn mutation resulted in a significant reduction of HGS in the nervous system of the Hgstn/tn mice, it differentially affected HGS levels in non-neuronal tissues (Fig 2B). Examination of the heart, liver, spleen, kidney, adrenal gland, thalamus, testis, and ovaries from the Hgstn/tn mice revealed a striking absence of pathology in these tissues, suggesting that HGS provides an essential function that is unique to the nervous system.
(A) qPCR analysis of Hgs mRNA expression in 4-week-old Hgs+/+ tissues. Transcript level is expressed relative to Hgs level found in the brain. (B) Representative immunoblot of HGS expression in 4-week-old Hgs+/+ (wt) and Hgstn/tn (tn) mice. β-actin was used as a loading control. (C) qPCR analysis of Hgs levels from the brains of Hgs+/+ mice during postnatal development. (D) Representative immunoblot analysis of HGS expression from embryonic day 15 (E15) to postnatal day 35 (P35) in Hgs+/+ (wt) and Hgstn/tn (tn) brain lysates. β-tubulin is used as a loading control. (E) Quantitation of developmental time course of HGS expression in Hgs+/+ (wt) and Hgstn/tn (tn) mice expressed as percent of E15 Hgs+/+ levels. Symbols represent unpaired t-tests corrected for multiple comparisons using the Holm-Sidak method. A one way anova with a Geisser-Greenhouse adjustment demonstrated a significant difference between time points. (F) Quantitation of HGS expression in Hgstn/tn mice expressed as a percent of Hgs+/+ controls at each developmental time point. Data are shown as ± SE. Symbols represent unpaired t-tests. *p<0.05 and ***p<0.001.
Because Hgstn/tn mice display a progressive neurological disease starting around 3 weeks of age, it was important to establish a developmental profile of Hgs expression in the brain. We found that Hgs levels undergo a normal down regulation in the Hgs+/+ mice during early postnatal development (Fig 2C). Immunoblot analysis also showed the highest levels of HGS during embryonic development, with abundance decreasing throughout postnatal development (Fig 2D and 2E). The M89V mutation led to reduced expression of HGS at all time points examined (Fig 2D–2F), with the most severe loss of HGS occurring during the time when the neurological phenotypes were most pronounced in the Hgstn/tn mice. In addition to the primary immunoreactive band that migrated at approximately 110 kDa, a second higher molecular weight band migrating at approximately 120 kDa, which may represent a post-translationally modified form of HGS [40–42], was also detected early in development.
Absence of cell death in the hippocampus of Hgstn/tn mice
A previous study of a neuronal-specific knockout of Hgs demonstrated multiple deficits in the hippocampus that included increased ubiquitin staining of CA3 pyramidal cells, increased CA3 pyramidal cell death, and reduced CA3 pyramidal cell numbers . To determine whether the Hgstn/tn mice exhibited any alterations in the number of CA3 pyramidal cells or an increase in cell death, we measured the number of CA3 cells and looked for evidence of increased cell death by performing Nissl and activated caspase-3 staining, respectively, in the hippocampi of wild type and Hgstn/tn mice. Unlike what was reported for the neuronal-specific Hgs knockout mice, we did not detect any change in the number of CA3 pyramidal cells or an increase in cell death markers in the Hgstn/tn hippocampus (Fig 3A). In addition, the levels of hippocampal myelin basic protein were similar in the Hgstn/tn and Hgs+/+ mice. Moreover, while increased glial fibrillary acid protein (GFAP) abundance is often associated with neurodegeneration, there was no increase in GFAP immunoreactivity in the hippocampus of the Hgstn/tn mice compared to wild type controls (Fig 3A). Similar to what we observed in total brain extracts, there was a significant reduction in both HGS and STAM1 levels in the hippocampus of the Hgstn/tn mice. Since mutations in CHMP2B are associated with neurodegeneration in humans, we examined the effect of loss of HGS on CHMP2B levels and found no detectable differences in the hippocampus between the Hgstn/tn or wild type controls. Examination of the levels of the receptor tyrosine kinases TrkA and TrkB, which are putative substrates for HGS, in hippocampal extracts from the Hgstn/tn and Hgs+/+ mice also did not reveal any significant differences in expression (Fig 3B and 3C).
(A) CA3 hippocampal sections from 4-week-old Hgs+/+ and Hgstn/tn mice were stained for Nissl, myelin basic protein (MBP), glial fibrillary protein (GFAP) and activated caspase 3. Inset is positive control (E13 embryo) for activated caspase-3. Nuclei are stained with DAPI (blue). (B) Representative immunoblot of hippocampal lysates from 4-week-old Hgs+/+ and Hgstn/tn mice. Blots were probed for the ESCRT components HGS, STAM1, and CHMP2B, the receptor tyrosine kinases TrkA and TrkB, and the autophagic markers LC3 and p62. (C) Quantitation of immunoblots from hippocampal lysates. n = 3 mice per genotype. Data are shown as mean ± SE. *p<0.05 and ***p<0.001.
As a component of the endosome, HGS has been implicated in the maturation of autophagosomes, as the loss of HGS expression results in increased levels of markers of autophagy in mammalian cell lines . To investigate if HGS is required for autophagy in neurons, we examined the expression of the autophagosome marker microtubule-associated protein 1A/1B-light chain 3 (LC3) and the autophagy substrate p62 in hippocampal lysates from wild type and Hgstn/tn mice. In contrast to the increased levels of LC3 and p62 that are observed when autophagy is impaired , we detected a reduction in the levels of both LC3 and p62 in the hippocampus of the Hgstn/tn mice as compared to controls (Fig 3B and 3C). Together, these data indicate that loss of HGS does not appear to result in increased cell death or a significant impairment of autophagy in the hippocampus of the Hgstn/tn mice.
Hgstn/tn mice exhibit motor and sensory deficits
Several neurological diseases are caused by mutations that lie within genes involved in the endosomal sorting of membrane proteins [45–48]. To examine whether HGS deficiency resulted in motor and sensory deficits commonly seen in patients with inherited neuropathies, we performed a series of behavioral assays on our mutant Hgs mouse lines. By 3 weeks of age, the Hgstn/tn mice exhibited significant motor deficits as demonstrated by the presence of clawed paws, decreased locomotion in an open field assay, impaired rotarod performance and an increased time to transverse an elevated beam compared to controls (Fig 4A–4D). In addition, the Hgstn/tn mice also demonstrated increased tactile sensitivity that was consistent with a heightened pain response when examined using the von Frey assay (Fig 4E) and had reduced forelimb muscle strength as compared to age-matched controls (Fig 4F).
(A) Reduced HGS expression results in clawed paws in Hgstn/tn mice. Behavioral assays of (B) open field, (C) rotarod, (D) elevated beam, (E) von Frey and (F) forelimb grip strength for Hgs+/+ (black), Hgstn/+, Hgstn/tn and HgsKO/+ mice. n = 6 mice per genotype for all assays except rotarod, where n = 4. Symbols represent unpaired t-tests corrected for multiple comparisons using the Holm-Sidak method. Data are shown as mean ± SE and n>6 animals per genotype for all assays except rotarod, where n = 4. A two-way anova demonstrated a significant effect of genotype on rotarod and elevated beam performance. Data are shown as mean ± SE. *p<0.05, **p<0.01 and ***p<0.001.
The initial description of the tn mice indicated that the heterozygous tn mice displayed motor abnormalities in a prolonged swimming assay . We therefore investigated whether heterozygous Hgstn/+ and HgsKO/+ mice also exhibited motor and sensory abnormalities in our assays. Both the HgsKO/+ mice and the Hgstn/+ mice displayed increased pain sensitivity and reduced muscle strength (Fig 4E and 4F), indicating that the tn mutation is a loss-of-function mutation and that a 50% loss of HGS is sufficient to cause peripheral nervous system dysfunction.
Hgstn/tn mice display hypermyelination, dysmyelination, myelin infoldings, and increased axonal caliber
Alterations in axon number or peripheral nerve myelination are common features of inherited peripheral neuropathies and are thought to be important contributors to motor and sensory dysfunction. To examine whether loss of HGS expression results in axonal loss, demyelination, or dysmyelination that could contribute to the behavioral deficits in the Hgstn/tn mice, we compared the sciatic nerves of 4-week-old Hgs+/+ and Hgstn/tn mice by transmission electron microscopy. Although no change in the density of myelinated and unmyelinated axons was found in the Hgstn/tn mice (Fig 5A and 5B), there was a significant increase in the diameter of myelinated axons and a significant decrease in the diameter of unmyelinated axons in the 4-week-old Hgstn/tn mice as compared to controls (Fig 5C). This increase in the average axonal diameter of myelinated fibers was attributed to a shift in distribution towards a greater number of large diameter axons in the Hgstn/tn mice (Fig 5D). Morphometric analysis of myelin structure also revealed a small but significant decrease in the G-ratio (the ratio of the inner axonal diameter to the total fiber diameter) of sciatic nerves from the Hgstn/tn mice (Fig 5E). This decrease was attributed to a 22% increase in the myelin thickness of small-diameter axons that are between 1.0 to 2.0 μm in diameter (Fig 5F, circled region).
(A) Electron micrograph of sciatic nerves from 4-week-old Hgstn/tn and Hgs+/+ mice. Scale bar, 2 μm. Arrowheads indicate hypermyelinated fibers, curved arrows indicated disorganized myelin and arrows indicate demyelination. (B) Quantitation of axon density in myelinated and unmyelinated nerves. (C) Quantitation of average myelinated and unmyelinated axon diameters. (D) Histogram of frequency of axon diameters demonstrating an increase in large diameter myelinated axons in the sciatic nerves of Hgstn/tn mice relative to Hgs+/+ controls. Shaded region represents axonal size distribution from Hgs+/+ mice. An unpaired t-test with a Welch’s correction demonstrated a significant difference in the distribution of axonal size frequency between Hgs+/+ and Hgstn/tn mice. (E) Quantitation of the ratio of axon diameter to total fiber thickness (G-ratio). Symbols represent unpaired t-tests. (F) Relationship between myelin thickness and axon diameter in Hgs+/+ and Hgstn/tn sciatic nerves. Circled region depicts 1.0–2.0 μm diameter axons that are affected in the Hgstn/tn sciatic nerves. (G) Representative micrographs of myelin pathology in Hgstn/tn nerves demonstrating (1–2) Tomaculous fibers, (3–5) myelin infoldings compared to (6) Hgs+/+controls. n = 3 mice per genotype. Scale bar, 5 μm. Data are shown as mean ± SE. *p<0.05 and ***p<0.001.
Several alterations in myelin structure were also observed in the sciatic nerves of the Hgstn/tn mice (Fig 5G). These alterations included the presence of tomacula, a prominent thickening of compact myelin with redundant loops, which likely contributed to the decreased G-ratio observed in the Hgstn/tn mice. Additionally, many regions of the myelin sheaths were disorganized in the Hgstn/tn mice (Fig 5G1–5G2) and contained structural alterations such as myelin infoldings (Fig 5G3–5G5) as compared to controls (Fig 5G6).
The changes in myelination that were observed in the Hgstn/tn mice could be attributed to loss of HGS in either axons or Schwann cells. However, when we examined HGS expression in the sciatic nerves of wild type mice by indirect immunofluorescence (Fig 6), we found that HGS staining did not overlap with the neurofilament staining in sciatic nerve axons. Rather, when Schwann cells were visualized with antibodies to the cytoplasmic protein S100β, HGS localized to the external boundary of the Schwann cell body. These findings are in agreement with a previous study detecting HGS transcripts in Schwann cells .
Top panel, cross sections of sciatic nerves stained with antibodies against neurofilament (NF, green) and HGS (red). Bottom panel, sciatic nerves were stained with antibodies to the Schwann cell marker S100β (green) and HGS (red). Scale bar, 10 μm.
ESCRT and RTK expression in sciatic nerves of Hgstn/tn mice
In cell culture models, the stability of STAM1 appears to be dependent upon HGS expression in a transcript-independent manner [16,50]. However, this relationship between ESCRT-0 components has not been investigated in the nervous system. We therefore examined the effect of the tn mutation on the expression of ESCRT components and their putative substrates in the sciatic nerves of the Hgstn/tn mice. While the HGS levels were reduced by 50% in the sciatic nerves of 4-week-old Hgstn/tn mice compared to controls, there were no significant differences in the levels of STAM1, tumor susceptibility protein 101 (TSG101) or epidermal growth factor receptor substrate 15 (EPS15) in the sciatic nerve extracts from the Hgstn/tn and Hgs+/+ mice (Fig 7A–7C). Analysis of receptor tyrosine kinases (RTKs) sorted by the ESCRT pathway showed that loss of HGS resulted in a significant reduction in both the full length (TrkB.FL) and truncated (TrkB.T1) isoforms of TrkB in the sciatic nerves of the Hgstn/tn mice that was not associated with a corresponding reduction in TrkB mRNA levels (Fig 7D–7F). In contrast, reduction of HGS did not affect the level of either the epidermal-growth factor receptor (EGFR) or the receptor tyrosine-protein kinase erbB-2 (ERBB2) (Fig 7D and 7E).
(A) Representative immunoblot of ESCRT expression in sciatic nerve extracts. β-tubulin was used as a loading control. (B) Quantitation of immunoblots of ESCRT expression in sciatic nerve extracts. (C) qPCR analysis of ESCRT-0 components in the sciatic nerve. (D) Representative immunoblot of TrkB.FL and TrkB.T1, EGFR and ERBB2 in sciatic nerves. β-tubulin was used as a loading control. (E) Quantitation of receptor tyrosine kinases in the sciatic nerve. (F) qPCR analysis of TrkB and BDNF in the sciatic nerve. Symbols represent unpaired t-tests corrected for multiple comparisons using the Holm-Sidak method. Data are shown as mean ± SE. n > 3 mice per genotype. **p<0.01 and ***p<0.001.
Hgstn/tn mice have reduced STAM1 expression in the spinal cord but do not exhibit motor neuron loss or altered levels of RTKs
Since loss of HGS resulted in a dramatic motor phenotype in the Hgstn/tn mice, but had only a modest effect on peripheral nerve myelination, we examined the effect of reduced HGS expression on the abundance of ESCRT-0 components in the spinal cords of 4-week-old mice (Fig 8A and 8B). Despite the significant increase in Hgs transcript levels in the Hgstn/tn mice (Fig 8C), HGS levels were reduced 70% in the spinal cords of the Hgstn/tn mice compared to controls (Fig 8A and 8B). Similarly, we also observed an 80% reduction in the levels of STAM1 in the spinal cords of the Hgstn/tn mice with no corresponding decrease in Stam1 transcript abundance (Fig 8A–8C). When we examined whether the loss of HGS affected the abundance of other proteins reported to interact with HGS [51–53], there was no difference in the levels of EPS15 or TSG101 in the spinal cords of the Hgstn/tn and Hgs+/+ mice (Fig 8A and 8B). Although HGS appears to influence the abundance of some receptor tyrosine kinases in immortalized cell lines [22,53–58] and TrkB in the sciatic nerves (Fig 7), the levels of EGFR, TrkA and TrkB found in the spinal cords of the Hgstn/tn mice were similar to those observed in the Hgs+/+ control mice (Fig 8A and 8B).
(A) Representative immunoblot and (B) quantitation of the ESCRT-0 proteins HGS and STAM1, the ESCRT-I protein TSG101, the ESCRT-0 interacting proteins EPS15, and the receptor tyrosine kinases TrkB, TrkA and EGFR in the spinal cords of Hgs+/+ and Hgstn/tn mice. β-tubulin was used as a loading control. (C) qPCR analysis of Hgs and Stam1 in the spinal cords of Hgs+/+ and Hgstn/tn mice. Levels are expressed relative to levels found in wild type Hgs+/+ mice. Symbols represent unpaired t-tests corrected for multiple comparisons using the Holm-Sidak method. Data are shown as mean ± SE. (D) Motor neuron counts from lumbar segments 4/5 from Hgs+/+ and Hgstn/tn mice. n = 3 mice per genotype. (E) Immunostaining of Hgs+/+ and Hgstn/tn L4/5 segments with GFAP. Scale bar, 100 μm. Data are shown as mean ± SE. n > 3 mice per genotype. ***p<0.001.
To determine if the movement disorder in the Hgstn/tn mice was associated with a loss of motor neurons, we compared motor neuron numbers in the ventral horn of 4- to 5-week-old Hgstn/tn and Hgs+/+ mice. Consistent with the axonal density studies on the sciatic nerves, there was no significant difference in the number of motor neurons (Fig 8D) in the lumbar 4/5 region between the Hgstn/tn and Hgs+/+ mice. However, loss of HGS in the Hgstn/tn mice did result in increased GFAP staining in the lumbar 4/5 region of the spinal cord (Fig 8E).
Reduced muscle growth and increased acetylcholine receptor expression in Hgstn/tn mice
The Hgstn/tn mice exhibit several signs of neuromuscular disease, including muscle weakness and decreased motor performance. When we compared the muscle mass between the Hgstn/tn mice and the Hgs+/+ controls, we detected a significant difference in gastrocnemius weights at 4 weeks of age (Fig 9A and 9B). While we did not detect angular muscle fibers or centrally located nuclei in the muscle sections of the Hgstn/tn mice, which are common features of motor neuron disease, there was a 32% reduction in muscle fiber size in the Hgstn/tn mice (Fig 9C). These changes were consistent with decreased motor neuron input onto the muscle fibers. Since acetylcholine receptor (AChR) abundance is inversely correlated with motor neuron input onto muscle fibers, we performed qPCR on gastrocnemius muscle RNA isolated from 4-week-old wild type and Hgstn/tn mice. Both the embryonic and adult acetylcholine receptor subunit mRNAs were significantly increased in the gastrocnemius muscles of the Hgstn/tn mice (Fig 9D).
(A) Wet weights of gastrocnemius muscles from 4 week-old Hgs+/+ and Hgstn/tn mice. (B) Ratio of gastrocnemius muscle weights to body mass. n > 6 mice per genotype for each time point. (C) Gastrocnemius muscle fiber size measurements for Hgs+/+ and Hgstn/tn mice. n > 6 mice per genotype. Symbols represent unpaired t-tests. (D) qPCR analysis of AChR-α, AChR-β, AChR-δ, AChR-ε, and AChR-γ mRNAs from the gastrocnemius muscles of 4-week-old Hgs+/+ and Hgstn/tn mice. n > 3 mice per genotype. Symbols represent unpaired t-tests corrected for multiple comparisons using the Holm-Sidak method. (E) Motor endplate pathology in the Hgstn/tn mice. TA muscle fibers from Hgs+/+ and Hgstn/tn mice containing the Thy1-Yfp transgene (green) were stained with TRITC-α-bungarotoxin (red) to label the postsynaptic receptors. The presynaptic axons and nerve terminals are shown in green. Arrowheads mark ultra-terminal sprouting, and curved arrows mark swollen presynaptic terminals. Scale bar, 20 μm. (F) Quantitation of terminal swellings and terminal sprouting from Hgs+/+ and Hgstn/tn mice. n > 6 mice per genotype. Symbols represent unpaired t-tests corrected for multiple comparisons using the Holm-Sidak method. (G) Histogram of endplate area defined by TRITC-α-bungarotoxin (red) labeling of the postsynaptic AChR in Hgs+/+ and Hgstn/tn mice. An unpaired t-test with a Welch’s correction demonstrated a significant difference in the distribution of endplate size frequency between Hgs+/+ and Hgstn/tn mice. n > 6 mice per genotype. Data are shown as mean ± SE. *p<0.05, **p<0.01 and ***p<0.001.
Loss of HGS results in structural and functional changes at the NMJ
Alterations in motor endplate structure are found in several models of neuromuscular disease [59–62]. Using mice that express yellow fluorescent protein (YFP) in the motor axons to visualize motor neuron terminals from tibialis anterior (TA) muscles, we found that every postsynaptic AChR cluster in the wild type mice was innervated by a motor neuron axon (Fig 9E). Although all of the AChR clusters from the 4-week-old Hgstn/tn mice were also innervated, we observed a significant increase in the number of terminals that exhibited either terminal swellings or sproutings (Fig 9F), which are phenotypes that are often observed in mice with motor neuron disease [59,62,63]. In addition, there was a significant increase in endplate size in the Hgstn/tn mice (Fig 9G), which resembles the increase in endplate area observed in mice lacking the vesicular acetylcholine transporter . These results are consistent with the idea that reduced HGS expression results in decreased neurotransmitter release onto Hgstn/tn muscles.
By sorting internalized membrane proteins from the endosome to the lysosome, the ESCRT complexes are thought to regulate the turnover of internalized cargo . To investigate whether loss of HGS altered endosome or MVB abundance at motor neuron terminals, we compared the NMJs from wild type and Hgstn/tn TA muscles by electron microscopy (Fig 10A). Loss of HGS expression resulted in an increase in the number of endosomal-like structures in the Hgstn/tn mice (Fig 10A and 10B). While we did not observe any MVBs in the electron micrographs taken from wild type NMJs, we observed several MVBs (0.23 MVBs/μm2) in the motor neuron terminals of the Hgstn/tn mice. No significant difference was observed in the number of autophagosomes in the NMJs of the Hgstn/tn and Hgs+/+mice.
(A) Representative electron micrographs of NMJs in the TA muscle from 4-week-old Hgs+/+ and Hgstn/tn mice. Arrowheads point to endosomes-like structures. Asterisk marks an MVB in the Hgstn/tn presynaptic terminal. No MVBs were observed in Hgs+/+ terminals. Scale bar, 500 μm. (B) Quantitation of endosome-like structures at the motor axon terminals. Symbol represents unpaired t-tests. (C) A 50% reduction in EPC amplitudes was observed in the endplates from 3-week-old Hgstn/tn mice (n = 12 endplates from 6 mice) as compared to controls (n = 12 endplates from 5 mice). (D) MEPC amplitudes were reduced in the Hgstn/tn mice (n = 19 endplates from 6 mice) to 46% of Hgs+/+ controls (n = 15 endplates from 8 mice). (E) Quantal content was significantly lower in Hgstn/tn mice (n = 8 endplates from 6 mice) than in Hgs+/+ controls (n = 12 endplates from 5 mice). (F) Reduced HGS expression results in a 65% reduction in MEPC frequency at the TA muscles of Hgstn/tn mice (n = 17 endplates from 6 mice) compared to Hgs+/+controls (n = 14 endplates from 5 mice). Symbol represents unpaired t-tests **p<0.01 and ***p<0.001.
HGS is thought to have a role in regulating exocytosis through its interactions with components of presynaptic nerve terminals [23,52]. To test whether HGS is required to maintain neurotransmitter release, we used two-electrode voltage-clamp analysis to study the release of acetylcholine at the NMJs of 3-week-old Hgstn/tn and Hgs+/+ mice and observed a pronounced effect of HGS reduction on neurotransmitter release in the TA muscles of the Hgstn/tn mice (Fig 10C). The amplitude of evoked neurotransmitter release, measured as endplate currents (EPCs) and obtained by stimulating sciatic nerves, was decreased by 50% in the Hgstn/tn mice as compared to controls (Fig 10C). The EPC amplitude is determined by both the number of synaptic vesicles released after nerve stimulation (quantal content) and the amplitude of the muscle response to the neurotransmitter released from a single vesicle (quantal amplitude) [60,64]. The amplitude of miniature endplate currents (MEPCs), representing a response to a single quanta or vesicle, was also reduced in the Hgstn/tn mice compared to controls (Fig 10D). This finding suggests that there was either a decrease in the amount of neurotransmitter per vesicle or that there was a reduction in the sensitivity or abundance of post-synaptic receptors in the Hgstn/tn mice. However, the increase in AChR expression observed in the Hgstn/tn mice compared to controls, and the similarites between the phenotypes of the Hgstn/tn mice and mice lacking the vesicular ACh transporter, both suggest that there was a reduction in the level of acetylcholine found in the synaptic vesicles of the Hgstn/tn mice. The finding of decreased MEPC amplitudes in the Hgstn/tn mice also suggests that HGS may be required post-synaptically for stable AChR expression.
In addition, a reduction in quantal content (the number of vesicles released by evoked stimulation), which is calculated by dividing EPC amplitude by MEPC amplitude, was also observed in the Hgstn/tn mice compared to controls (Fig 10E). To further examine the effect of HGS loss on presynaptic function, we measured the frequency of spontaneous neurotransmitter release and determined that there was a 66% decrease in MEPC frequency in the Hgstn/tn mice compared to controls (Fig 10F). These findings indicate that loss of HGS severely affects synaptic transmission by reducing acetylcholine release at the NMJ and that these changes in presynaptic function likely contribute to the motor deficits seen in the Hgstn/tn mice.
Loss of HGS results in the accumulation of ubiquitinated proteins at the synapse
HGS is involved in the sorting of ubiquitinated proteins, and our studies indicate that loss of HGS has a profound effect on synaptic transmission at the NMJ. To investigate whether HGS is required for the sorting of ubiquitinated proteins at the synapse, we examined the level of ubiquitinated proteins in both the total and synaptosomal fractions prepared from cerebral cortices of wild type and Hgstn/tn mice. While the level of ubiquitin conjugates in the spinal cord, sciatic nerve and cortex were similar between the Hgstn/tn mice and controls, we observed a 2-fold increase in the level of ubiquitinated proteins isolated from the cortical synaptosomes of the Hgstn/tn mice (Fig 11A and 11B). This compartment-specific effect of HGS reduction on the levels of ubiquitin conjugates suggests that HGS is involved in the sorting of ubiquitinated proteins at the synapse and that proper endosomal sorting at the NMJ is required to maintain synaptic transmission.
(A) Representative immunoblot of ubiquitin conjugates from the nervous system of 4-week-old Hgs+/+ (wt) and Hgstn/tn (tn) mice. (B) Quantitation of immunoblots. n = 3 per genotype. Symbols represent unpaired t-tests corrected for multiple comparisons using the Holm-Sidak method. Data are shown as mean ± SE. **p<0.001.
These studies demonstrate that the neurological deficits observed in the tn mice are caused by a hypomorphic mutation in the ESCRT-0 component Hgs which significantly reduced HGS levels in the central nervous system. By 4 weeks of age, the Hgstn/tn mice show significant defects in motor and sensory function as well as reduced muscle development, increased muscle AChR expression, terminal sproutings and swellings of motor axons, and increased numbers of endosomes and MVBs at the motor neuron axon terminals. In addition to these structural changes in the motor axon terminals, we also observed a significant reduction in both spontaneous and evoked vesicular release of acetylcholine at the NMJs of the Hgstn/tn mice, suggesting that HGS-dependent sorting of proteins at the endosome is required to maintain synaptic transmission at the NMJ. Analysis of the level of ubiquitinated proteins revealed a significant increase in ubiquitin conjugates specifically in the synaptosomal fraction of the Hgstn/tn mice as compared to controls. While the numbers of myelinated and unmyelinated peripheral nerves in the Hgstn/tn mice were similar to the numbers observed in wild type mice, the reduced HGS expression resulted in an increase in myelin thickness and dysmyelination of the sciatic nerve axons in the Hgstn/tn mice. These results demonstrate that HGS is required to support both the myelination of peripheral nerves and synaptic transmission at the NMJ.
HGS regulates the sorting and trafficking of ubiquitinated, internalized receptors on the endosome [42,65,66]. Our finding that the M89V mutation in the VHS domain had variable effects on HGS expression in the different non-neuronal tissues examined suggests that HGS stability is dictated, at least in part, by its interaction with specific binding partners . Alternatively, a variable demand for the ESCRT pathway may also be responsible for the differential effects of the M89V mutation on HGS expression in the various Hgstn/tn tissues.
There are several similarities between the myelination defects detected in the Hgstn/tn mice and those observed in the brain-derived neurotrophic factor (BDNF)-overexpressing mice . Although we found no evidence for altered BDNF levels in the Hgstn/tn mice, there was a significant reduction in TrkB in the sciatic nerves of Hgstn/tn mice as compared to controls. However, there was no difference in the levels of TrkB mRNA detected in the Hgstn/tn mice and controls, suggesting that HGS promotes TrkB stability by facilitating recycling to the plasma membrane and preventing trafficking to the lysosome. This conclusion is consistent with previous reports that HGS can regulate the recycling of TrkB.FL in neuronal culture . It is possible that the limited effects of loss of HGS on TrkB expression may reflect a partial loss of HGS in the Schwann cells of the Hgstn/tn mice. Our finding that STAM1 expression is not altered in Hgstn/tn sciatic nerve extracts, but is reduced in spinal cord and brain extracts, may indicate that STAM1 associates with other proteins in Schwann cells to stabilize its expression or that the level of HGS expression was not sufficiently reduced in Schwann cells to destabilize STAM1. In addition, since HGS interacts with the NF2 gene MERLIN in Schwann cells [68,69], loss of this complex may contribute to the changes observed in the levels of TrkB. Since the observed changes in myelin thickness are very subtle, they are unlikely to be a major contributor to the neurological deficits observed in the tn mice.
Although the Hgstn/tn mice represent the first report linking ESCRT-0 to neuromuscular disease, mutations in the ESCRT-III component CHMP2B have been linked to amyotrophic lateral sclerosis [27,28], and patients with CHMP2B mutations exhibit phenotypes consistent with lower motor neuron disease . The Hgstn/tn mice also show signs of dysfunction of the lower motor neurons, including motor incoordination, muscle weakness, muscle atrophy, hypokinesis, and reduced synaptic transmission at the NMJ. These deficits are not associated with loss of motor neuron cell bodies or axons in the Hgstn/tn mice, or with denervation of the NMJ. In immortalized cell lines, expression of mutant CHMP2B resulted in the formation of dysmorphic endosomes , increased levels of autophagy markers, and the formation of ubiquitin-positive inclusions , suggesting that the motor neuron damage results from a block in autophagic clearance of ubiquitinated proteins. Although data from mammalian cell lines suggests that HGS is required for the maturation of autophagic vesicles, as depletion of HGS resulted in increased LC3 levels and decreased numbers of LC3/lysosome-associated membrane glycoprotein 1 positive structures in cell culture , loss of HGS resulted in reduced levels of the autophagy markers LC3 and p62 in the hippocampus of the Hgstn/tn mice, indicating that loss of HGS does not appear to result in a blockade in autophagy in neurons.
Our studies demonstrate that HGS is required for synaptic transmission at the NMJ. The reductions in MEPC and EPC amplitudes and quantal content are consistent with reduced vesicle number and/or release at the NMJ of the Hgstn/tn mice. These findings are also consistent with a previous report that showed that mutation of the neuronal Rab35 GTPase activating protein skywalker in Drosophila leads to an increase in the readily releasable pool of vesicles, enhanced neurotransmitter release and increased HGS-dependent protein sorting at the NMJ , suggesting that the ESCRT machinery is required for synaptic vesicle rejuvenation and removing defective synaptic vesicle proteins at the NMJ. The increased levels of ubiquitinated synaptic proteins detected in the Hgstn/tn mice suggests that an ESCRT-dependent mechanism for clearing ubiquitinated proteins at synapses is also important to maintaining synaptic transmission in mammals. Alternatively, the increase in ubiquitinated conjugates may be an indirect effect caused by disruption of the endosomal sorting pathway.
HGS is known to interact with synaptic vesicle proteins and could therefore directly affect vesicle trafficking [52,56]. For example, by binding to SNAP25 [23,51], HGS can displace vesicle-associated membrane protein 2 and inhibit SNARE complex formation, thereby blocking neurotransmitter secretion and endosomal fusion [23,70]. While the presence of enlarged vesicles would be the predicted effect of HGS loss, we did not detect an increase in the size of the endosomes at motor neuron axon terminals in the Hgstn/tn mice, but instead found an increase in the number of endosomes and MVBs at the NMJs of the Hgstn/tn mice. Previous reports from a proteomic screen identified mammalian uncoordinated-18, a component of the synaptic vesicle fusion protein complex, as a protein that could interact with the ubiquitin-interacting motif of HGS . HGS has also been shown to inhibit the fusion of vesicles with the early endosome . Together, these results provide evidence that HGS interacts with components of the synaptic vesicle release machinery and plays a direct role in synaptic transmission.
Given that loss of HGS results in a predominantly neurological phenotype in the Hgstn/tn mice, it is surprising that a neuronal-specific deletion of HGS  leads to such a mild phenotype compared to what we observed in our studies. Whereas Hgstn/tn mice die by 5 weeks of age and present with ataxia, decreased muscle size, and reduced strength, the neuronal-specific deletion of HGS did not affect gait or grip strength, and there was no reported effect of HGS loss on viability . However, it is possible that the conditional knockout allele used by Tamai et al. , which utilized a rat synapsin Cre driver , may not have led to a reduction of HGS in the motor neurons, or that the level of HGS was not reduced as much as what is observed in the Hgstn/tn mice, thereby resulting in a milder phenotype.
Identification of the tn mutation in HGS has provided a new model for investigating the role of the ESCRT pathway in the nervous system. Our identification of motor and sensory phenotypes in both the Hgstn/+ and HgsKO/+ mice demonstrates that loss of HGS results in an autosomal dominant inheritance pattern similar to that observed in human cases of amyotrophic lateral sclerosis and Charcot-Marie-Tooth disease [27,28,35]. Hereditary neuralgic amyotrophy, an autosomal dominant form of recurrent focal neuropathy, is the only neurological disorder that has been mapped near HGS on chromosome 17q25 . Mutations in Septin 9 have been found in many, but not all, cases of hereditary neuralgic amyotrophy, making HGS a good candidate gene for other cases of this disease. With our demonstration that HGS is required for motor neuron function, it will now be possible to determine if HGS is involved in other neurological disorders in humans.
Materials and Methods
The tn mutation spontaneously arose on the C3H/HeJ inbred mouse strain at The Jackson Laboratory in 1959. We generated a congenic line of B6.C3Hgstn mice by backcrossing the tn mutation onto the C57BL/6J background for at least 12 generations. The tn mice were maintained by intercrossing tn sibling heterozygotes (Hgstn/+). Hgs knockout heterozygotes (Hgstm1Sor/+, stock number 003539) were obtained from The Jackson Laboratory, and sibling pairs were intercrossed to maintain the strain. Research was conducted using equal numbers of male and female mice. Wild type littermates or age-matched C57BL/6J mice (Hgs+/+) were used as controls.
All mice were maintained in our breeding colony at the University of Alabama at Birmingham, which is fully accredited by the Association for Assessment and Accreditation of Laboratory Animal Care International. All research was approved by the UAB IACUC committee and complied with the United States Animal Welfare Act and other federal statutes and regulations relating to animals and experiments involving animals, and adhered to principles stated in the Guide for the Care and Use of Laboratory Animals, United States National Research Council.
The tn mutation was previously mapped to distal chromosome 11 . Small nucleotide polymorphism (SNP) analysis localized the tn mutation to a 2.8 Mb region on the distal end of chromosome 11 flanked by rs27043138 and rs3675603.
RNA transcriptome analysis
Total RNA was isolated from brain lysates of 4-week-old Hgstn/tn and Hgs+/+ mice using RNA-STAT60 (Tel-Test, Friendswood, TX) and subsequently purified using an RNeasy Mini Kit (Qiagen Sciences, Valencia, CA). RNA-seq experiments were carried out at the Hudson Alpha Genome Services Laboratory (Huntsville, Alabama). Two μg of total RNA underwent quality control (Bioanalyzer; all RIN values > 9.5), and was prepared for directional RNA sequencing at Hudson Alpha using NEBNext reagents (New England Biolabs) according to manufacturer’s recommendations with minor modifications (including the use of custom library adapters and indexes). RNA libraries were quantified with the Kapa Library Quant Kit (Kapa Biosystems), and underwent sequencing (50 bp paired-end directional reads; ~70M reads/sample) on an Illumina sequencing platform (HiSeq2000).
Exon 4 of Hgs was amplified from genomic DNA of Hgstn/tn and Hgs+/+ mice. The PCR products were sequenced by The Genomics Core Facility of the Heflin Center for Genomic Science (Birmingham, AL).
Total RNA was isolated from specified tissues using RNA-STAT60 and reverse transcribed using the Superscript VILO cDNA synthesis kit (Life Technologies). Individual gene assays were purchased from Applied Biosystems for each of the RNAs analyzed. ΔΔCt values were generated using Hgs (Mm00468635_m1), Stam (Mm00488457_m1), AChRα (Mm00431629_m1), AChRβ (Mm00680412_m1), AChRδ (Mm00445545_m1), AChrδ (Mm00437419_m1), AChRε (Mm00437411_m1), Bdnf (Mm04230607_s1) and TrkB Mm00435422_m1). Taqman gene assays with 18S (Mm03928990_g1) and β-actin (Mm00607939_s1) served as internal standards. qPCR results are shown as the average of three different amplifications of cDNAs that were generated from at least three different mice. Unpaired Student’s t tests were conducted on ΔΔCt values from each genotype to determine their significance.
Isolation of proteins
Mice of appropriate age and genotype were asphyxiated with CO2 or deeply anesthetized via isoflurane prior to rapid decapitation. Tissues were removed and homogenized in a modified RIPA buffer containing 50 mM Tris, pH 7.5, 150 mM NaCl, 5 mM MgCl2, 0.5 mM EGTA, 1 mM EDTA, 0.5% SDS, 1% Triton X-100, and 1% sodium deoxycholate. Complete protease inhibitors (Roche, Indianapolis, IN), phosphatase inhibitor cocktail I (Sigma Aldrich, St. Louis, MO), and 50 μM PR-619 (Life Sensors, Malvern, PA) were added to the homogenization buffer. Samples were homogenized in 1X Laemmli buffer, sonicated, and boiled. After homogenization, tissues were centrifuged at 17,000 x g for 10 min at 4°C, and supernatants were removed and immediately frozen at—80°C. Protein concentrations were determined by using the bicinchoninic acid (BCA) protein assay kit from Pierce (Rockford, IL).
Proteins were resolved on either 10% Tris-glycine gels or 4–20% Novex Tris-glycine gels (Life Technologies) and transferred onto nitrocellulose or PVDF membranes. Immunoblots were probed for HGS, STAM1, TSG101, EPS15, EGFR (Santa Cruz, Dallas, TX), TrkA and TrkB (Millipore, Billerica, MA), CHMP2B (Abcam, Cambridge, MA), ERBB2, p62, LC3 (4108) and cleaved caspase 3 (Cell Signaling, Danvers, MA), mylein basic protein (Biolegend, Dedham, MA), GFAP (Dako, Carpinteria, CA) and ubiquitin (UAB Hybridoma Facility, Birmingham, AL). β-tubulin and β-actin (Developmental Hybridoma Bank, Iowa City, IA) were used for loading controls. Primary antibodies were diluted in 1X phosphate buffered saline containing 0.1% NP-40 and either 2% BSA or 1% non-fat dry milk, and proteins were detected by using an anti-mouse or anti-rabbit HRP-conjugated secondary antibody (Southern Biotechnology Associates, Birmingham, AL) and SuperSignal West Pico Chemiluminescent Substrate (Thermo Scientific, Rockford, IL).
Quantitation of immunoblots
Blots were scanned using a Hewlett-Packard Scanjet 3970 (Palo Alto, CA) and quantitated using ImageJ (NIH, Bethesda, MD) or UN-SCAN-IT software (Orem, Utah). Each value represents the mean and standard error from at least two blots using at least three different animals per genotype. Unpaired t-tests, corrected for multiple comparisons using the Holm- Šídák method, were utilized to determine significant effects between genotypes. One-way ANOVAs with the Geisser-Greenhouse correction were used to analyze the developmental expression patterns of HGS.
Body and muscle wet weight analysis
Gastrocnemius muscles were collected from 4-week-old Hgs+/+ and Hgstn/tn mice. Muscle and body weights were determined for at least six animals per genotype, and values are reported as the average muscle or body mass ± SE.
Brain sections were prepared and stained as previously described .
Sciatic nerve immunostaining and confocal microscopy
Sciatic nerves were dissected from 4-week-old wild type mice and immediately submersed in ice cold 4% PFA for 1 h. Sciatic nerves were cryopreserved in PBS containing 30% sucrose overnight at 4°C. Nerves were embedded in OCT (Tissue-Tek; Sakura Finetek USA) and 20 μM sections were cut for analysis. Sections were blocked in PBS containing 10% normal goat serum for 1 h at room temperature. Primary antibodies (HGS, S100β and Neurofilament) were diluted 1:200 in PBS containing 10% normal goat serum and incubated with sections overnight at 4°C. Sections were washed two times with PBS at room temperature and then incubated with secondary antibodies labeled with Alexa Fluor 488 or 568 dye (Invitrogen). Confocal imaging was performed on a Nikon C2 laser scanning confocal microscope using the NIS element advance imaging software package version 4.2 (Nikon, Melville, NY). Images were captured at 40x using a 0.3 μM z-step.
NMJ immunostaining and confocal imaging.
Whole mount immunostaining of tibialis anterior (TA) muscles was performed as described . Briefly, TA muscles were dissected and immersed in ice-cold 2% PFA in PBS for 1 h. Muscles were then teased into bundles and transferred to 1% PFA in PBST (PBS + 1% Triton) overnight at 4°C with constant rocking. Endplate size was determined by tracing the circumference of the α-bungarotoxin-positive post-synaptic AChR cluster and computing area using ImageJ software. Quantitation of axonal sprouts and swellings were performed using ImageJ software. Over 150 synapses from Hgs+/+ and Hgstn/tn mice were quantified.
Motor and sensory performance was assayed at 3 to 4 weeks of age with Hgs+/+, Hgstn/tn, Hgstn/+, and HgsKO/+ mice (n ≥ 4). Before each behavioral assay, animals were habituated to the testing room for 30 min. Unpaired Student’s t-tests were performed on open field, grip strength and von Frey data. Two-way ANOVA was utilized to determine significance between genotypes on rotarod and elevated beam assays. Unpaired Student’s t-tests were utilized to determine the significance of each trial.
Animals were handled at least three days prior to open field testing. Locomotor activity was measured in an open-field arena (43.2 cm x 43.2 cm x 30.5 cm) for 15 min by an automatic video tracking system (Med Associated, St. Albans, VT). The first 5 min were not analyzed to account for habituation to the open field chamber.
Motor coordination and balance were tested by placing mice on an accelerating rotarod (ENV-575, Med Associates) and recording latency to fall. The rotarod initially started rotating at 3.5 rpm and accelerated to 35 rpm over a 5 min period. Each mouse performed 3 trials separated by 1 h.
Motor coordination and proprioception were tested by the elevated beam assay as previously described . Four trials were performed with each trial consisting of 3 repetitions of the assay.
The San Diego Instrument Grip Strength System (San Diego, CA) was used to assay mouse grip strength. The maximum amount of force generated from forelimbs was recorded. Each trial consisted of 12 repetitions of the assay with the two highest and two lowest data points dropped from final analysis.
Von Frey analysis
Animals were habituated to an open gridded floor chamber for 5 min. A series of 10 von Frey fibers varying from 0.4 g to 60 g of force (Ugo Basile, Comerio, Italy) was applied from below the wire mesh chamber in ascending order beginning with the smallest fiber. The fiber was applied to the central region of the plantar surface to avoid the foot pads. The hind paw withdrawal threshold was determined by Dixon’s formula.
NMJ transmission electron microscopy
TA muscle tissues were fixed in 4% paraformaldehyde in 0.1 M sodium cacodylate buffer for 1 h. Fixed muscle fibers were stained with α-bungarotoxin and dissected to isolate regions of muscles containing NMJs. Muscles were washed in 0.1 M sodium cacodylate buffer and then post-fixed in 1% osmium tetroxide for 1 h in the dark. After rinsing with sodium cacodylate, the samples were dehydrated in increasing concentrations of acetone (50% for 10 min, 75% for 10 min, 90% for 10 min, 95% for 10 min, 100% for 4 x 10 min). Muscles were transitioned to epoxy resin (Electron Microscopy Sciences, Hatfield, IL) by rotating the samples overnight in a 50:50 solution of epoxy:acetone. The samples were then immersed in fresh 100% resin several times throughout the next day and baked at 65°C overnight. Ultra-thin cross-sections were collected using a Leica EM-UC6 ultramicrosome (Buffalo Grove, IL) and stained for contrast with uranyl acetate and lead citrate. Samples were viewed using an FEI Tecnai T-12 electron microscope (Delmont, PA) with a Hamamatsu digital camera (Bridgewater, N.J).
Quantitation of motor neuron number
For quantitation of motor neuron numbers, transverse frozen sections of lumbar spinal cords (L4 /L5) from 7-week-old wt and axJ mice were prepared and stained with cresyl violet as previously described .
Morphometric analysis of the NMJ
Ultra-thin sections of muscle tissues were scanned for the presence of NMJs. Micrographs were taken at 4400-6500x magnification. A total of 14 synapses were analyzed from Hgs+/+ mice (n = 3), and 27 synapses from Hgstn/tn mice (n = 3) were quantified. Endosomes were defined as single membrane intracellular vesicles that were at least 100 nm in feret diameter, and MVBs were defined as endosomes with at least 2 ILVs within the lumen. Endosomes and MVBs were quantified and normalized to the size of the synapse.
Transmission electron microscopy of sciatic nerves
Sciatic nerves were excised from 4-week-old Hgs+/+ and Hgstn/tn mice and immersed in 6% gluteraldehyde/2% paraformaldehyde in 0.1 M sodium cacodylate buffer for at least 1.5 h at room temperature. Samples were processed as described above for NMJ analysis.
Morphometric analysis of sciatic nerves
Photomicrographs for morphometric analysis were obtained by systematically covering adjacent but non-overlapping fields to measure axon and myelin diameter, myelin thickness, and myelin defects. The feret diameter was calculated to determine axon and myelin caliper. The G-ratio was also calculated by dividing the axon diameter by the myelin diameter. Quantitation was performed using ImageJ software. A total of 595 myelinated axons from Hgs+/+ mice (n = 3) and 574 axons from Hgstn/tn mice (n = 3) were quantified. Micrographs taken at 240x magnification were utilized to calculate axon density of myelinated fibers, while micrographs taken at 1100x were used to quantitate the density of unmyelinated fibers.
All experiments were carried out in vitro at room temperature on the sciatic nerve and TA muscles from 3- to 4-week-old mice. For dissection, mice were deeply anesthetized with isofluorane. The TA muscle was dissected free from the extensor digitorum longus (EDL) muscle, partially bisected, and folded apart to flatten the muscle before pinning it down. Because the sciatic nerve innervates both EDL and TA muscles, we transected the EDL and posterior portion of the TA muscle to eliminate excessive muscle contraction. The TA muscle was perfused with Tyrode's solution (137 mM NaCl, 2.8 mM KCl, 1.8 mM CaCl2, 1.1 mM MgCl2, 11.9 mM NaHCO3, 0.33 mM NaH2PO4, and 11.2 mM dextrose, pH 7.4, when bubbled with a mixture of 95% O2 and 5% CO2) at 30°C. Intracellular potentials and currents were measured using an Axoclamp-2A amplifier system and glass microelectrodes filled with 3 M KCl (resistance, 10–15 MΩ). Using the two-microelectrode voltage-clamp system, synaptic currents, including miniature endplate currents (MEPCs) and endplate currents (EPCs), were obtained at -60 mV holding potential. The currents were digitized at 50 μs per point and were stored, captured, and analyzed using pClamp 9.0 software (Molecular Devices). EPCs were elicited by stimulating the corresponding sciatic nerve with rectangular pulses of 0.05 ms duration. During single shock stimulation, the nerve was stimulated at 0.2 Hz. The amplitude decay and time to peak of the EPCs and MEPCs were captured and subsequently analyzed with pClamp 9.2 software and the Mini Analysis Program (Synaptosoft). Quantal content was determined by dividing MEPC amplitude with EPC amplitude from the same endplate [78–80].
Synaptosomes were prepared from 4-week-old cerebral cortices of wild type and tn mice as described .
Conceived and designed the experiments: JAWa BJB GPS SEP RJM SMW EP GDK. Performed the experiments: JAWa BJB JHV JAWi MI ADH SEP EP GDK TMD. Analyzed the data: JAWa BJB JHV GPS TMD SEP RJM SMW. Contributed reagents/materials/analysis tools: AJB. Wrote the paper: JAWa BJB JHV JAWi AJB SMW.
- 1. Morgan JR, Comstra HS, Cohen M, Faundez V (2013) Presynaptic membrane retrieval and endosome biology: defining molecularly heterogeneous synaptic vesicles. Cold Spring Harb Perspect Biol 5: a016915. pmid:24086045
- 2. Rodahl LM, Stuffers S, Lobert VH, Stenmark H (2009) The role of ESCRT proteins in attenuation of cell signalling. Biochem Soc Trans 37: 137–142. pmid:19143618
- 3. Clague MJ, Urbe S (2001) The interface of receptor trafficking and signalling. J Cell Sci 114: 3075–3081. pmid:11590234
- 4. Henne WM, Stenmark H, Emr SD (2013) Molecular mechanisms of the membrane sculpting ESCRT pathway. Cold Spring Harb Perspect Biol 5.
- 5. Hurley JH (2010) The ESCRT complexes. Crit Rev Biochem Mol Biol 45: 463–487. pmid:20653365
- 6. Wollert T, Hurley JH (2010) Molecular mechanism of multivesicular body biogenesis by ESCRT complexes. Nature 464: 864–869. pmid:20305637
- 7. Skibinski G, Parkinson NJ, Brown JM, Chakrabarti L, Lloyd SL, et al. (2005) Mutations in the endosomal ESCRTIII-complex subunit CHMP2B in frontotemporal dementia. Nat Genet 37: 806–808. pmid:16041373
- 8. Andersen OM, Reiche J, Schmidt V, Gotthardt M, Spoelgen R, et al. (2005) Neuronal sorting protein-related receptor sorLA/LR11 regulates processing of the amyloid precursor protein. Proc Natl Acad Sci U S A 102: 13461–13466. pmid:16174740
- 9. Willnow TE, Andersen OM (2013) Sorting receptor SORLA—a trafficking path to avoid Alzheimer disease. J Cell Sci 126: 2751–2760. pmid:23813966
- 10. Warner LE, Mancias P, Butler IJ, McDonald CM, Keppen L, et al. (1998) Mutations in the early growth response 2 (EGR2) gene are associated with hereditary myelinopathies. Nat Genet 18: 382–384. pmid:9537424
- 11. Asao H, Sasaki Y, Arita T, Tanaka N, Endo K, et al. (1997) Hrs is associated with STAM, a signal-transducing adaptor molecule. Its suppressive effect on cytokine-induced cell growth. J Biol Chem 272: 32785–32791. pmid:9407053
- 12. Bache KG, Raiborg C, Mehlum A, Stenmark H (2003) STAM and Hrs are subunits of a multivalent ubiquitin-binding complex on early endosomes. J Biol Chem 278: 12513–12521. pmid:12551915
- 13. Clague MJ, Urbe S (2003) Hrs function: viruses provide the clue. Trends Cell Biol 13: 603–606. pmid:14624836
- 14. Clague MJ, Liu H, Urbe S (2012) Governance of endocytic trafficking and signaling by reversible ubiquitylation. Dev Cell 23: 457–467. pmid:22975321
- 15. Clague MJ, Urbe S (2010) Ubiquitin: same molecule, different degradation pathways. Cell 143: 682–685. pmid:21111229
- 16. Kobayashi H, Tanaka N, Asao H, Miura S, Kyuuma M, et al. (2005) Hrs, a mammalian master molecule in vesicular transport and protein sorting, suppresses the degradation of ESCRT proteins signal transducing adaptor molecule 1 and 2. J Biol Chem 280: 10468–10477. pmid:15640163
- 17. Belleudi F, Leone L, Maggio M, Torrisi MR (2009) Hrs regulates the endocytic sorting of the fibroblast growth factor receptor 2b. Exp Cell Res 315: 2181–2191. pmid:19362549
- 18. Baldys A, Raymond JR (2009) Critical role of ESCRT machinery in EGFR recycling. Biochemistry 48: 9321–9323. pmid:19673488
- 19. Komada M, Kitamura N (2005) The Hrs/STAM complex in the downregulation of receptor tyrosine kinases. J Biochem 137: 1–8. pmid:15713877
- 20. Roxrud I, Raiborg C, Pedersen NM, Stang E, Stenmark H (2008) An endosomally localized isoform of Eps15 interacts with Hrs to mediate degradation of epidermal growth factor receptor. J Cell Biol 180: 1205–1218. pmid:18362181
- 21. Sirisaengtaksin N, Gireud M, Yan Q, Kubota Y, Meza D, et al. (2014) UBE4B protein couples ubiquitination and sorting machineries to enable epidermal growth factor receptor (EGFR) degradation. J Biol Chem 289: 3026–3039. pmid:24344129
- 22. Hanyaloglu AC, McCullagh E, von Zastrow M (2005) Essential role of Hrs in a recycling mechanism mediating functional resensitization of cell signaling. Embo J 24: 2265–2283. pmid:15944737
- 23. Bean AJ, Seifert R, Chen YA, Sacks R, Scheller RH (1997) Hrs-2 is an ATPase implicated in calcium-regulated secretion. Nature 385: 826–829. pmid:9039916
- 24. Sun W, Yan Q, Vida TA, Bean AJ (2003) Hrs regulates early endosome fusion by inhibiting formation of an endosomal SNARE complex. Journal of Cell Biology 162: 125–137. pmid:12847087
- 25. Uytterhoeven V, Kuenen S, Kasprowicz J, Miskiewicz K, Verstreken P (2011) Loss of skywalker reveals synaptic endosomes as sorting stations for synaptic vesicle proteins. Cell 145: 117–132. pmid:21458671
- 26. Neefjes J, van der Kant R (2014) Stuck in traffic: an emerging theme in diseases of the nervous system. Trends Neurosci 37: 66–76. pmid:24411104
- 27. Parkinson N, Ince PG, Smith MO, Highley R, Skibinski G, et al. (2006) ALS phenotypes with mutations in CHMP2B (charged multivesicular body protein 2B). Neurology 67: 1074–1077. pmid:16807408
- 28. Cox LE, Ferraiuolo L, Goodall EF, Heath PR, Higginbottom A, et al. (2010) Mutations in CHMP2B in lower motor neuron predominant amyotrophic lateral sclerosis (ALS). PLoS One 5: e9872. pmid:20352044
- 29. Lo Giudice M, Neri M, Falco M, Sturnio M, Calzolari E, et al. (2006) A missense mutation in the coiled-coil domain of the KIF5A gene and late-onset hereditary spastic paraplegia. Arch Neurol 63: 284–287. pmid:16476820
- 30. Reid E, Kloos M, Ashley-Koch A, Hughes L, Bevan S, et al. (2002) A kinesin heavy chain (KIF5A) mutation in hereditary spastic paraplegia (SPG10). Am J Hum Genet 71: 1189–1194. pmid:12355402
- 31. Patel H, Cross H, Proukakis C, Hershberger R, Bork P, et al. (2002) SPG20 is mutated in Troyer syndrome, an hereditary spastic paraplegia. Nature Genetics 31: 347–348. pmid:12134148
- 32. Lee SM, Chin LS, Li L (2012) Charcot-Marie-Tooth disease-linked protein SIMPLE functions with the ESCRT machinery in endosomal trafficking. J Cell Biol 199: 799–816. pmid:23166352
- 33. Lee SM, Olzmann JA, Chin LS, Li L (2011) Mutations associated with Charcot-Marie-Tooth disease cause SIMPLE protein mislocalization and degradation by the proteasome and aggresome-autophagy pathways. J Cell Sci 124: 3319–3331. pmid:21896645
- 34. Gerding WM, Koetting J, Epplen JT, Neusch C (2009) Hereditary motor and sensory neuropathy caused by a novel mutation in LITAF. Neuromuscul Disord 19: 701–703. pmid:19541485
- 35. Street VA, Bennett CL, Goldy JD, Shirk AJ, Kleopa KA, et al. (2003) Mutation of a putative protein degradation gene LITAF/SIMPLE in Charcot-Marie-Tooth disease 1C. Neurology 60: 22–26. pmid:12525712
- 36. Meier H (1967) The neuropathy of teetering, a neurological mutation in the mouse. Arch Neurol 16: 59–66. pmid:6024256
- 37. Lohi O, Poussu A, Mao Y, Quiocho F, Lehto VP (2002) VHS domain—a longshoreman of vesicle lines. FEBS Lett 513: 19–23. pmid:11911875
- 38. Ren X, Hurley JH (2010) VHS domains of ESCRT-0 cooperate in high-avidity binding to polyubiquitinated cargo. EMBO J 29: 1045–1054. pmid:20150893
- 39. Komada M, Soriano P (1999) Hrs, a FYVE finger protein localized to early endosomes, is implicated in vesicular traffic and required for ventral folding morphogenesis. Genes Dev 13: 1475–1485. pmid:10364163
- 40. Polo S, Sigismund S, Faretta M, Guidi M, Capua MR, et al. (2002) A single motif responsible for ubiquitin recognition and monoubiquitination in endocytic proteins. Nature 416: 451–455. pmid:11919637
- 41. Zhang J, Du J, Lei C, Liu M, Zhu AJ (2014) Ubpy controls the stability of the ESCRT-0 subunit Hrs in development. Development 141: 1473–1479. pmid:24574010
- 42. Urbe S, Mills IG, Stenmark H, Kitamura N, Clague MJ (2000) Endosomal localization and receptor dynamics determine tyrosine phosphorylation of hepatocyte growth factor-regulated tyrosine kinase substrate. Mol Cell Biol 20: 7685–7692. pmid:11003664
- 43. Tamai K, Toyoshima M, Tanaka N, Yamamoto N, Owada Y, et al. (2008) Loss of hrs in the central nervous system causes accumulation of ubiquitinated proteins and neurodegeneration. Am J Pathol 173: 1806–1817. pmid:19008375
- 44. Tamai K, Tanaka N, Nara A, Yamamoto A, Nakagawa I, et al. (2007) Role of Hrs in maturation of autophagosomes in mammalian cells. Biochem Biophys Res Commun 360: 721–727. pmid:17624298
- 45. Kaneko-Oshikawa C, Nakagawa T, Yamada M, Yoshikawa H, Matsumoto M, et al. (2005) Mammalian E4 is required for cardiac development and maintenance of the nervous system. Molecular and Cellular Biology 25: 10953–10964. pmid:16314518
- 46. Neveling K, Martinez-Carrera LA, Holker I, Heister A, Verrips A, et al. (2013) Mutations in BICD2, which encodes a golgin and important motor adaptor, cause congenital autosomal-dominant spinal muscular atrophy. Am J Hum Genet 92: 946–954. pmid:23664116
- 47. Puls I, Jonnakuty C, LaMonte BH, Holzbaur ELF, Tokito M, et al. (2003) Mutant dynactin in motor neuron disease. Nature Genetics 33: 455–456. pmid:12627231
- 48. Verhoeven K, De Jonghe P, Coen K, Verpoorten N, Auer-Grumbach M, et al. (2003) Mutations in the small GTP-ase late endosomal protein RAB7 cause Charcot-Marie-Tooth type 2B neuropathy. American Journal of Human Genetics 72: 722–727. pmid:12545426
- 49. Buchstaller J, Sommer L, Bodmer M, Hoffmann R, Suter U, et al. (2004) Efficient isolation and gene expression profiling of small numbers of neural crest stem cells and developing Schwann cells. J Neurosci 24: 2357–2365. pmid:15014110
- 50. Mizuno E, Kawahata K, Okamoto A, Kitamura N, Komada M (2004) Association with Hrs is required for the early endosomal localization, stability, and function of STAM. J Biochem 135: 385–396. pmid:15113837
- 51. Bean AJ, Davanger S, Chou MF, Gerhardt B, Tsujimoto S, et al. (2000) Hrs-2 regulates receptor-mediated endocytosis via interactions with Eps15. J Biol Chem 275: 15271–15278. pmid:10809762
- 52. Kwong J, Roundabush FL, Hutton Moore P, Montague M, Oldham W, et al. (2000) Hrs interacts with SNAP-25 and regulates Ca(2+)-dependent exocytosis. J Cell Sci 113 (Pt 12): 2273–2284. pmid:10825299
- 53. Lu Q, Hope LW, Brasch M, Reinhard C, Cohen SN (2003) TSG101 interaction with HRS mediates endosomal trafficking and receptor down-regulation. Proc Natl Acad Sci U S A 100: 7626–7631. pmid:12802020
- 54. Chanut-Delalande H, Jung AC, Baer MM, Lin L, Payre F, et al. (2010) The Hrs/Stam complex acts as a positive and negative regulator of RTK signaling during Drosophila development. PLoS One 5: e10245. pmid:20422006
- 55. Huang SH, Zhao L, Sun ZP, Li XZ, Geng Z, et al. (2009) Essential role of Hrs in endocytic recycling of full-length TrkB receptor but not its isoform TrkB.T1. J Biol Chem 284: 15126–15136. pmid:19351881
- 56. Lloyd TE, Atkinson R, Wu MN, Zhou Y, Pennetta G, et al. (2002) Hrs regulates endosome membrane invagination and tyrosine kinase receptor signaling in Drosophila. Cell 108: 261–269. pmid:11832215
- 57. Raiborg C, Malerod L, Pedersen NM, Stenmark H (2008) Differential functions of Hrs and ESCRT proteins in endocytic membrane trafficking. Exp Cell Res 314: 801–813. pmid:18031739
- 58. Razi M, Futter CE (2006) Distinct roles for Tsg101 and Hrs in multivesicular body formation and inward vesiculation. Mol Biol Cell 17: 3469–3483. pmid:16707569
- 59. Chen PC, Qin LN, Li XM, Walters BJ, Wilson JA, et al. (2009) The proteasome-associated deubiquitinating enzyme Usp14 is essential for the maintenance of synaptic ubiquitin levels and the development of neuromuscular junctions. J Neurosci 29: 10909–10919. pmid:19726649
- 60. Kong L, Wang X, Choe DW, Polley M, Burnett BG, et al. (2009) Impaired synaptic vesicle release and immaturity of neuromuscular junctions in spinal muscular atrophy mice. J Neurosci 29: 842–851. pmid:19158308
- 61. de Castro BM, De Jaeger X, Martins-Silva C, Lima RD, Amaral E, et al. (2009) The vesicular acetylcholine transporter is required for neuromuscular development and function. Mol Cell Biol 29: 5238–5250. pmid:19635813
- 62. Fischer LR, Culver DG, Tennant P, Davis AA, Wang M, et al. (2004) Amyotrophic lateral sclerosis is a distal axonopathy: evidence in mice and man. Exp Neurol 185: 232–240. pmid:14736504
- 63. Frey D, Schneider C, Xu L, Borg J, Spooren W, et al. (2000) Early and selective loss of neuromuscular synapse subtypes with low sprouting competence in motoneuron diseases. J Neurosci 20: 2534–2542. pmid:10729333
- 64. Del Castillo J, Katz B (1954) Quantal components of the end-plate potential. J Physiol 124: 560–573. pmid:13175199
- 65. Komada M, Masaki R, Yamamoto A, Kitamura N (1997) Hrs, a tyrosine kinase substrate with a conserved double zinc finger domain, is localized to the cytoplasmic surface of early endosomes. J Biol Chem 272: 20538–20544. pmid:9252367
- 66. Raiborg C, Bache KG, Gillooly DJ, Madshus IH, Stang E, et al. (2002) Hrs sorts ubiquitinated proteins into clathrin-coated microdomains of early endosomes. Nat Cell Biol 4: 394–398. pmid:11988743
- 67. Tolwani RJ, Cosgaya JM, Varma S, Jacob R, Kuo LE, et al. (2004) BDNF overexpression produces a long-term increase in myelin formation in the peripheral nervous system. J Neurosci Res 77: 662–669. pmid:15352212
- 68. Gutmann DH, Haipek CA, Burke SP, Sun CX, Scoles DR, et al. (2001) The NF2 interactor, hepatocyte growth factor-regulated tyrosine kinase substrate (HRS), associates with merlin in the "open" conformation and suppresses cell growth and motility. Hum Mol Genet 10: 825–834. pmid:11285248
- 69. Scoles DR, Huynh DP, Chen MS, Burke SP, Gutmann DH, et al. (2000) The neurofibromatosis 2 tumor suppressor protein interacts with hepatocyte growth factor-regulated tyrosine kinase substrate. Hum Mol Genet 9: 1567–1574. pmid:10861283
- 70. Sun W, Yan Q, Vida TA, Bean AJ (2003) Hrs regulates early endosome fusion by inhibiting formation of an endosomal SNARE complex. J Cell Biol 162: 125–137. pmid:12847087
- 71. Pridgeon JW, Webber EA, Sha D, Li L, Chin LS (2009) Proteomic analysis reveals Hrs ubiquitin-interacting motif-mediated ubiquitin signaling in multiple cellular processes. Febs J 276: 118–131. pmid:19019082
- 72. Zhu Y, Romero MI, Ghosh P, Ye Z, Charnay P, et al. (2001) Ablation of NF1 function in neurons induces abnormal development of cerebral cortex and reactive gliosis in the brain. Genes Dev 15: 859–876. pmid:11297510
- 73. Kilpatrick BS, Eden ER, Schapira AH, Futter CE, Patel S (2013) Direct mobilisation of lysosomal Ca2+ triggers complex Ca2+ signals. J Cell Sci 126: 60–66. pmid:23108667
- 74. Lane PW (1962) Teetering. Mouse News Letter 27: 38.
- 75. Maltare A, Nietz AK, Laszczyk AM, Dunn TS, Ballestas ME, et al. (2014) Development and characterization of monoclonal antibodies to detect klotho. Monoclon Antib Immunodiagn Immunother 33: 420–427. pmid:25513981
- 76. Crimmins S, Jin Y, Wheeler C, Huffman AK, Chapman C, et al. (2006) Transgenic rescue of ataxia mice with neuronal-specific expression of ubiquitin-specific protease 14. J Neurosci 26: 11423–11431. pmid:17079671
- 77. Blondet B, Carpentier G, Ait-Ikhlef A, Murawsky M, Rieger F (2002) Motoneuron morphological alterations before and after the onset of the disease in the wobbler mouse. Brain Research 930: 53–57. pmid:11879795
- 78. Bhattacharyya BJ, Day JW, Gundeck JE, Leonard S, Wollmann RL, et al. (1997) Desensitization of mutant acetylcholine receptors in transgenic mice reduces the amplitude of neuromuscular synaptic currents. Synapse 27: 367–377. pmid:9372559
- 79. Wilson SM, Bhattacharyya B, Rachel RA, Coppola V, Tessarollo L, et al. (2002) Synaptic defects in ataxia mice result from a mutation in Usp14, encoding a ubiquitin-specific protease. Nat Genet 32: 420–425. pmid:12368914
- 80. Groshong JS, Spencer MJ, Bhattacharyya BJ, Kudryashova E, Vohra BP, et al. (2007) Calpain activation impairs neuromuscular transmission in a mouse model of the slow-channel myasthenic syndrome. J Clin Invest 117: 2903–2912. pmid:17853947
- 81. Dunkley PR, Jarvie PE, Robinson PJ (2008) A rapid Percoll gradient procedure for preparation of synaptosomes. Nat Protoc 3: 1718–1728. pmid:18927557